X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218461
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-24-2024-24602.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217605
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217669
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217330
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-26-2023-55742.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217137
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217655
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/marksans-pharma-gets-final-usfda-nod-for-generic-version-of-famotidine-tablets/articleshow/98538255.cms
https://www.indianpharmapost.com/news/zydus-receives-final-approval-from-usfda-for-famotidine-injection-13334
https://www.fiercepharma.com/pharma/opening-round-zantac-litigation-gsk-scores-decisive-win
https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-sanofi-haleon-shares-stabilise-after-zantac-litigation-slump-2022-08-12/
https://www.businesswire.com/news/home/20220811005562/en/Amneal-launches-4-new-Generic-products-including-Vasopressin-single-dose
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216427
https://www.expresspharma.in/zydus-lifesciences-receives-final-approval-from-us-fda-for-famotidine-tablets/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216441
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216441
https://www.pharmacytimes.com/view/camber-pharma-launches-generic-pepcid-
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215822
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215630
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215766
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215767
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216030
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215689
https://www.indiainfoline.com/article/news-sector-pharma-healthcare/lupin-launches-authorized-generic-version-of-duexis-in-the-us-121091600302_1.html#:~:text=Ibuprofen%20and%20Famotidine%20Tablets%20(RLD,(IQVIA%20MAT%20July%202021).&text=Lupin%20has%20announced%20the%20launch,mg%2C%20of%20Horizon%20Medicines%20LLC.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211890
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-10-2021-1615353629.pdf
https://www.moneycontrol.com/news/business/dr-reddys-launches-generic-product-in-the-us-to-treat-gastroesophageal-reflux-disease-5987901.html
https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-therapeutics-tracker
https://www.medpagetoday.com/infectiousdisease/covid19/88119?xid=nl_mpt_DHE_2020-08-18&eun=g655567d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%20Top%20Cat%20HeC%20%202020-08-18&utm_term=NL_Daily_DHE_dual-gmail-definition
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-29-2020-1596012065.pdf
https://www.sciencenews.org/article/coronavirus-covid-19-heartburn-medicine-pepcid-does-not-work-antiviral
https://english.alarabiya.net/en/coronavirus/2020/05/24/Clinical-trials-of-coronavirus-drug-favipiravir-enter-final-stage.html
https://www.business-standard.com/article/companies/famotidine-shortage-in-us-may-benefit-indian-pharmaceutical-companies-120050701419_1.html
https://www.cnbc.com/2020/04/28/heartburn-drug-trial-shows-reasonable-confidence-famotidine-could-help-treat-coronavirus-hospital-ceo-says-.html
https://edition.cnn.com/2020/04/27/health/famotidine-coronavirus-northwell-trial/index.html
https://www.fiercepharma.com/manufacturing/need-a-safe-antacid-for-heartburn-fda-declares-pepcid-nexium-and-others-free-ndma
https://www.pharmacompass.com/pdf/news/duexis-ibuprofen-and-famotidine-horizon-pharma-inc-and-horizon-pharma-usa-inc-v-alkem-laboratories-ltd-1531314741.pdf
https://www.fiercepharma.com/pharma/specialty-pharmacy-scrutiny-hits-again-state-s-focus-horizon-meds
http://www.firstpost.com/business/dr-reddys-lab-recalls-famotidine-tablets-from-us-market-as-drug-fails-impurities-specifications-4159935.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-18-2017-1508294527.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-13-2017-1505277974.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-9-2017-1502256126.pdf
http://www.cbsnews.com/news/heartburn-acid-reflux-drugs-ppi-associated-with-increased-risk-kidney-damage/
http://www.fiercepharma.com/pharma/look-out-valeant-horizon-et-al-payers-patients-target-pricey-meds-combo-cheap-generics
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-us-food-and-drug-administration-nod-for-two-drugs/articleshow/52006823.cms
http://www.pharma-excipients.ch/2016/03/03/enhancing-the-stability-of-a-famotidine-tablet-formulation-through-use-ofstarch-1500/
Market Place
Share 
